Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy
Psoriatic nail symptoms are frequent in psoriasis, affecting up to 80% of patients. Therapy responses to nail symptoms are often limited. In this multicentre non-interventional prospective study, 267 patients with nail involvement were treated with adalimumab for a period of 24 months. The efficacy...
Saved in:
Main Authors: | Georgios Kokolakis (Author), Frank Bachmann (Author), Kerstin Wolk (Author), Robert Sabat (Author), Sandra Philipp (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis
by: Zhanhan TANG, et al.
Published: (2023) -
Continuous growth reference from 24<sup>th </sup>week of gestation to 24 months by gender
by: Albertsson-Wikland Kerstin, et al.
Published: (2008) -
Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
by: Changkun Li, et al.
Published: (2023) -
Meta-analysis of efficacy and safety of adalimumab injection for arthropathic psoriasis
by: Nan LI, et al.
Published: (2019) -
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
by: Aline Lissa Okita, et al.
Published: (2020)